Accurate classification of ependymomas and medulloblastomas using Raman spectroscopy and pilot transcriptomic profiling

Key Points

• Accurate classification of ependymomas and medulloblastomas enhances diagnostic precision, potentially altering treatment pathways.
• Key evidence highlights successful distinction using Raman spectroscopy with notable accuracy metrics.
• Assessment using Raman spectroscopy and transcriptomic profiling aids in identifying specific molecular pathways related to tumor types.
• Supports the potential for more personalized treatment options based on precise tumor classification methods.